INVO Fertility (IVF) Cash from Investing Activities (2016 - 2026)
INVO Fertility (IVF) posted quarterly Cash from Investing Activities of -$210000.0 for Q1 2026, down 1333.45% year-over-year from $17025.5 in Q1 2025, and down 2504.81% quarter-over-quarter from -$8062.0 in Q3 2025.
INVO Fertility (IVF) Cash from Investing Activities (2016 - 2026) Analysis & Trends
INVO Fertility (IVF) has reported Cash from Investing Activities for 10 consecutive years, with -$210000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 1333.45% year-over-year to -$210000.0; the TTM figure through Mar 2026 stood at -$248158.0 (down 166.47% YoY), while the FY2024 annual figure was $363895.0, up 114.59% from the prior year.
- Cash from Investing Activities declined to -$210000.0 in Q1 2026 per IVF's latest filing, from -$8062.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $393134.0 in Q4 2024 and bottomed at -$2.3 million in Q3 2023.
- Historically, Cash from Investing Activities has averaged -$164023.9 across 5 years, with a median of -$8447.0 in 2023.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities plunged 74973.7% — and 2024, when it jumped 1080.94%.
- INVO Fertility's Cash from Investing Activities stood at $8583.0 in 2022, then jumped by 287.86% to $33290.0 in 2023, then surged by 1080.94% to $393134.0 in 2024, then sank by 102.05% to -$8062.0 in 2025, then sank by 2504.81% to -$210000.0 in 2026.
- Business Quant data shows IVF's Cash from Investing Activities at -$210000.0 in Q1 2026, -$8062.0 in Q3 2025, and -$15446.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -108.50 Mn |
| 10 | INVO Fertility | 2.38 Mn | 2.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -210,000.00 |
| Mar 31, 2026 | -210,000.00 |
| Sep 30, 2025 | -8,062.00 |
| Sep 30, 2025 | -8,062.00 |
| Jun 30, 2025 | -15,446.00 |
| Jun 30, 2025 | -15,446.00 |
| Mar 31, 2025 | -14,650.00 |
| Mar 31, 2025 | -14,650.00 |
| Dec 31, 2024 | 393,134.00 |
| Dec 31, 2024 | 393,134.00 |
| Jun 30, 2024 | -5,131.00 |
| Jun 30, 2024 | -5,131.00 |
| Mar 31, 2024 | -24,108.00 |
| Mar 31, 2024 | -24,108.00 |
| Dec 31, 2023 | 33,290.00 |
| Dec 31, 2023 | 33,290.00 |
| Sep 30, 2023 | -2.26 Mn |
| Sep 30, 2023 | -2.26 Mn |
| Jun 30, 2023 | -261,505.00 |
| Jun 30, 2023 | -261,505.00 |